NCT06248567View on ClinicalTrials.gov

Pharmacokinetics of ZSP1273 in Participants With Severe Kidney Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

April 30, 2024

Study Completion Date

May 30, 2024

Conditions
Kidney Impairment
Interventions
DRUG

ZSP1273

Oral

Trial Locations (1)

Unknown

The First Affiliated Hospital of Xiamen University, Xiamen

All Listed Sponsors
lead

Guangdong Raynovent Biotech Co., Ltd

INDUSTRY

NCT06248567 - Pharmacokinetics of ZSP1273 in Participants With Severe Kidney Disease | Biotech Hunter | Biotech Hunter